Logo image of BAM.CA

BROOKFIELD ASSET MGMT-A (BAM.CA) Stock Fundamental Analysis

TSX:BAM - Toronto Stock Exchange - CA1130041058 - Common Stock - Currency: CAD

77.19  -0.42 (-0.54%)

Fundamental Rating

5

Overall BAM gets a fundamental rating of 5 out of 10. We evaluated BAM against 82 industry peers in the Capital Markets industry. BAM has an average financial health and profitability rating. BAM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BAM was profitable.
BAM had a positive operating cash flow in the past year.
BAM had positive earnings in each of the past 5 years.
Of the past 5 years BAM 4 years had a positive operating cash flow.
BAM.CA Yearly Net Income VS EBIT VS OCF VS FCFBAM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

With a decent Return On Assets value of 6.32%, BAM is doing good in the industry, outperforming 78.31% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.08%, BAM is in the better half of the industry, outperforming 72.29% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.07%, BAM is in the better half of the industry, outperforming 72.29% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BAM is significantly below the industry average of 7.96%.
The 3 year average ROIC (1.27%) for BAM is below the current ROIC(4.07%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.32%
ROE 9.08%
ROIC 4.07%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.27%
ROIC(5y)3.38%
BAM.CA Yearly ROA, ROE, ROICBAM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 66.67%, BAM belongs to the best of the industry, outperforming 84.34% of the companies in the same industry.
BAM's Profit Margin has improved in the last couple of years.
BAM has a better Operating Margin (51.23%) than 80.72% of its industry peers.
In the last couple of years the Operating Margin of BAM has declined.
Industry RankSector Rank
OM 51.23%
PM (TTM) 66.67%
GM N/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
BAM.CA Yearly Profit, Operating, Gross MarginsBAM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80 100

6

2. Health

2.1 Basic Checks

BAM has more shares outstanding than it did 1 year ago.
BAM has a better debt/assets ratio than last year.
BAM.CA Yearly Shares OutstandingBAM.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
BAM.CA Yearly Total Debt VS Total AssetsBAM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

BAM has an Altman-Z score of 12.56. This indicates that BAM is financially healthy and has little risk of bankruptcy at the moment.
BAM's Altman-Z score of 12.56 is amongst the best of the industry. BAM outperforms 87.95% of its industry peers.
The Debt to FCF ratio of BAM is 2.09, which is a good value as it means it would take BAM, 2.09 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BAM (2.09) is better than 77.11% of its industry peers.
BAM has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BAM (0.15) is better than 63.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.09
Altman-Z 12.56
ROIC/WACCN/A
WACCN/A
BAM.CA Yearly LT Debt VS Equity VS FCFBAM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.37 indicates that BAM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.37, BAM is in the better half of the industry, outperforming 65.06% of the companies in the same industry.
BAM has a Quick Ratio of 1.37. This is a normal value and indicates that BAM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BAM (1.37) is better than 65.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
BAM.CA Yearly Current Assets VS Current LiabilitesBAM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

BAM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.76%, which is quite good.
Measured over the past years, BAM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.95% on average per year.
BAM shows a strong growth in Revenue. In the last year, the Revenue has grown by 264.78%.
The Revenue for BAM have been decreasing by -26.01% on average. This is quite bad
EPS 1Y (TTM)11.76%
EPS 3Y-34.73%
EPS 5Y-22.95%
EPS Q2Q%21.21%
Revenue 1Y (TTM)264.78%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-2.88%

3.2 Future

Based on estimates for the next years, BAM will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.88% on average per year.
BAM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.12% yearly.
EPS Next Y14.59%
EPS Next 2Y15.46%
EPS Next 3Y15.88%
EPS Next 5YN/A
Revenue Next Year11.37%
Revenue Next 2Y12.57%
Revenue Next 3Y10.12%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BAM.CA Yearly Revenue VS EstimatesBAM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
BAM.CA Yearly EPS VS EstimatesBAM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

BAM is valuated quite expensively with a Price/Earnings ratio of 37.29.
Compared to the rest of the industry, the Price/Earnings ratio of BAM indicates a slightly more expensive valuation: BAM is more expensive than 67.47% of the companies listed in the same industry.
BAM is valuated rather expensively when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 29.38, BAM can be considered very expensive at the moment.
BAM's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.89, BAM is valued a bit more expensive.
Industry RankSector Rank
PE 37.29
Fwd PE 29.38
BAM.CA Price Earnings VS Forward Price EarningsBAM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as BAM.
Industry RankSector Rank
P/FCF 124.97
EV/EBITDA N/A
BAM.CA Per share dataBAM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BAM has a very decent profitability rating, which may justify a higher PE ratio.
BAM's earnings are expected to grow with 15.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.56
PEG (5Y)N/A
EPS Next 2Y15.46%
EPS Next 3Y15.88%

3

5. Dividend

5.1 Amount

BAM has a Yearly Dividend Yield of 2.25%. Purely for dividend investing, there may be better candidates out there.
BAM's Dividend Yield is comparable with the industry average which is at 5.39.
BAM's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.25%

5.2 History

BAM has been paying a dividend for over 5 years, so it has already some track record.
BAM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
BAM.CA Yearly Dividends per shareBAM.CA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

125.58% of the earnings are spent on dividend by BAM. This is not a sustainable payout ratio.
DP125.58%
EPS Next 2Y15.46%
EPS Next 3Y15.88%
BAM.CA Yearly Income VS Free CF VS DividendBAM.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B
BAM.CA Dividend Payout.BAM.CA Dividend Payout, showing the Payout Ratio.BAM.CA Dividend Payout.PayoutRetained Earnings

BROOKFIELD ASSET MGMT-A

TSX:BAM (7/4/2025, 7:00:00 PM)

77.19

-0.42 (-0.54%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners17%
Inst Owner ChangeN/A
Ins Owners1.94%
Ins Owner ChangeN/A
Market Cap126.38B
Analysts68.57
Price Target80.54 (4.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.25%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP125.58%
Div Incr Years3
Div Non Decr Years3
Ex-Date05-30 2025-05-30 (0.4375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.17%
Min EPS beat(2)-1.13%
Max EPS beat(2)1.46%
EPS beat(4)2
Avg EPS beat(4)0.88%
Min EPS beat(4)-2.55%
Max EPS beat(4)5.74%
EPS beat(8)4
Avg EPS beat(8)1.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.41%
Min Revenue beat(2)-17.67%
Max Revenue beat(2)-17.15%
Revenue beat(4)0
Avg Revenue beat(4)-9.23%
Min Revenue beat(4)-17.67%
Max Revenue beat(4)-0.58%
Revenue beat(8)0
Avg Revenue beat(8)-8.6%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.08%
PT rev (3m)-6.9%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)-1.41%
EPS NY rev (1m)0.15%
EPS NY rev (3m)-1.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.59%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.91%
Valuation
Industry RankSector Rank
PE 37.29
Fwd PE 29.38
P/S 65.52
P/FCF 124.97
P/OCF 124.47
P/B 8.92
P/tB 8.92
EV/EBITDA N/A
EPS(TTM)2.07
EY2.68%
EPS(NY)2.63
Fwd EY3.4%
FCF(TTM)0.62
FCFY0.8%
OCF(TTM)0.62
OCFY0.8%
SpS1.18
BVpS8.65
TBVpS8.65
PEG (NY)2.56
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.32%
ROE 9.08%
ROCE 6.09%
ROIC 4.07%
ROICexc 4.18%
ROICexgc 4.38%
OM 51.23%
PM (TTM) 66.67%
GM N/A
FCFM 52.43%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.27%
ROIC(5y)3.38%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.93%
ROCE(5y)4.85%
ROICexcg growth 3Y-36.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y-36.35%
ROICexc growth 5YN/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.09
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 31.61
Cash Conversion N/A
Profit Quality 78.65%
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 12.56
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)18.12%
Cap/Sales(5y)11.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.76%
EPS 3Y-34.73%
EPS 5Y-22.95%
EPS Q2Q%21.21%
EPS Next Y14.59%
EPS Next 2Y15.46%
EPS Next 3Y15.88%
EPS Next 5YN/A
Revenue 1Y (TTM)264.78%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-2.88%
Revenue Next Year11.37%
Revenue Next 2Y12.57%
Revenue Next 3Y10.12%
Revenue Next 5YN/A
EBIT growth 1Y1072.58%
EBIT growth 3Y-62.73%
EBIT growth 5Y-39.83%
EBIT Next Year17.11%
EBIT Next 3Y17.48%
EBIT Next 5YN/A
FCF growth 1Y514.88%
FCF growth 3Y-25.34%
FCF growth 5Y-6.68%
OCF growth 1Y372.79%
OCF growth 3Y-24.26%
OCF growth 5Y-5.43%